Australian Healthcare Herald
SEE OTHER BRANDS

Catch up with healthcare and wellness news from Australia

Australian Healthcare Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Australian Healthcare Herald.

Press releases published on August 26, 2025

KFSHRC Adopts AI Brain Implant That Halves Parkinson’s Medication Needs

KFSHRC Adopts AI Brain Implant That Halves Parkinson’s Medication Needs

KFSHRC introduces AI-powered brain implant, offering Parkinson’s patients up to 50% less medication and better quality of life. RIYADH, SAUDI ARABIA, August 26, 2025 /⁨EINPresswire.com⁩/ -- King Faisal Specialist Hospital …

Healthcare Expansion Increases Anti-Microbial Coatings Market: Forecast to grow with 9.8% CAGR Through 2035

Healthcare Expansion Increases Anti-Microbial Coatings Market: Forecast to grow with 9.8% CAGR Through 2035

Healthcare Expansion Increases Anti-Microbial Coatings Market: Forecast to grow with 9.8% CAGR Through 2035 CA, UNITED STATES, August 26, 2025 /⁨EINPresswire.com⁩/ -- Anti-Microbial coatings market is projected to grow at a CAGR of 9.8% during the …

Digital Printing Packaging Market Size Worth USD 100.11 Billion by 2034 | CAGR 10.10% Forecast (2025–2034)

Digital Printing Packaging Market Size Worth USD 100.11 Billion by 2034 | CAGR 10.10% Forecast (2025–2034)

Digital Printing Packaging Market Size Worth USD 100.11 Billion by 2034 | CAGR 10.10% Forecast (2025–2034) CA, UNITED STATES, August 26, 2025 /⁨EINPresswire.com⁩/ -- Global Digital Printing Packaging Market was valued at USD 38.18 billion in 2024 and is …

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

MELBOURNE, Australia and NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”) is pleased to report positive data from its Phase 2 clinical trial of PSX-001 (formerly Psi-GAD), a psilocybin- …

Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference

Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference

MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 4:50 p.m. ET on Monday, September 8, 2025 …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions